Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects [Phase 3]
Phase 3 trial update for molidustat evaluating correction of renal anemia in non-dialysis chronic renal insufficiency patients.
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: A Study of Molidustat for Maintenance Treatment of Renal Anemia in Non-dialysis Subjects [Phase 3]
Phase 3 trial update for molidustat as maintenance treatment of renal anemia in non-dialysis subjects has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function [Phase 3]
Phase 3 trial evaluating two immunosuppressive strategies for renal function in chronic kidney disease has been completed.
-
FDA approval · 2021-01-26FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care de Mexico, S.A. de C.V.)
FDA approves a supplemental application for DELFLEX, a dialysis solution containing dextrose monohydrate and electrolytes, manufactured by F…
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease [Phase 3]
Phase 3 trial update on micro-particle curcumin for chronic kidney disease has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: Exercise to Prevent Muscle Mass and Functional Loss in Elderly Dialysis Patients [NA]
Clinical trial update on an exercise program aimed at preventing muscle mass and functional loss in elderly dialysis patients with chronic k…
-
FDA approval · 2021-01-20FDA Approved: VENOFER — Supplemental Application (Fresenius Medical Care Holdings, Inc.)
The FDA approved a supplemental application for VENOFER (iron sucrose) submitted by Fresenius Medical Care Holdings, Inc.
-
FDA approval · 2021-01-15FDA Approved: FERUMOXYTOL — Original Application (Sandoz Inc)
The FDA approved a generic version of ferumoxytol from Sandoz (Original Application), providing a generic option for iron deficiency anemia …
-
CLINICAL_TRIALS trial_result · 2021-01-14Clinical Trial Update: Low-volume vs High-volume Polyethylene Glycol Based Bowel Preparation for Colonoscopy in People Receiving Hemodialysis [Phase 4]
A phase 4 trial comparing low-volume versus high-volume polyethylene glycol bowel prep in people receiving hemodialysis for colonoscopy.
-
FDA approval · 2021-01-04FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for Sevelamer Carbonate by Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS withdrawal · 2020-12-29Clinical Trial Update: Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease [Phase 4]
Clinical trial for dapagliflozin in children with proteinuric chronic kidney disease was withdrawn after Phase 4.
-
FDA approval · 2020-12-28FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Exelan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Sevelamer carbonate submitted by Exelan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients [Phase 3]
Phase 3 trial comparing placebo to SBR759 for lowering phosphate in dialysis patients has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis [Phase 2]
Phase 2 trial update on SBR759 showing efficacy in lowering serum phosphate in chronic kidney disease patients on hemodialysis.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability and Activity of a New Phosphate Binder (SBR759) in Patients With Chronic Kidney Disease on Hemodialysis [Phase 1, Phase 2]
Clinical trial update for a Phase 1/2 study evaluating safety, tolerability, and activity of a new phosphate binder SBR759 in chronic kidney…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis [Phase 3]
Phase 3 trial results for roxadustat in anemia associated with chronic kidney disease in non-dialysis patients were posted.
-
CLINICAL_TRIALS research · 2020-12-17Clinical Trial Update: Breaking Down Care Process and Patient-level Barriers to Arteriovenous Access Creation Prior to Hemodialysis Initiation [NA]
Clinical trial update examining care processes and patient-level barriers to arteriovenous access creation before starting hemodialysis.
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Role of AST120 for Sarcopenia Prevention in Pre-dialysis Chronic Kidney Disease [Phase 4]
Phase 4 trial update evaluating AST120 for prevention of sarcopenia in pre-dialysis chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2020-12-16Clinical Trial Update: Comparing Safety and Immunogenicity of HEPLISAV-B® to Engerix-B® in Chronic Kidney Disease (CKD) Patients [Phase 3]
Phase 3 trial comparing safety and immunogenicity of HEPLISAV-B vaccine to Engerix-B in chronic kidney disease patients has completed with r…
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria [Phase 4]
Phase 4 clinical trial update examining HMG-CoA reductase add-on therapy in chronic kidney disease patients with proteinuria.
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Calcineurin Inhibitor Sparing After Kidney Transplantation [Phase 1, Phase 2]
Phase 1/2 trial evaluating strategies to spare calcineurin inhibitors after kidney transplantation to reduce CNI-related side effects.
-
FDA label_change · 2020-12-04FDA Approved: CINACALCET — Supplemental Application (Cipla USA Inc.)
The FDA approved a supplemental application for cinacalcet (Cipla USA Inc.), resulting in changes to CINACALCET's labeling.
-
FDA approval · 2020-11-20FDA Approved: SEVELAMER CARBONATE — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved Amneal Pharmaceuticals of New York LLC's generic sevelamer carbonate for the management of hyperphosphatemia in patients with c…
-
FDA approval · 2020-11-17FDA Approved: CALCIUM ACETATE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for calcium acetate capsules (667 mg) by Rising Pharma Holdings, Inc.
-
CLINICAL_TRIALS trial_result · 2020-11-12Clinical Trial Update: Clinical Study to Assess the Performance of the Dialyzer With Endexo™ [NA]
Completed clinical study evaluating the performance of the Dialyzer with Endexo™ in chronic kidney disease patients; results posted in 2020.